Idarubicin-containing regimen and G-CSF are capable of recruiting CD34+/DR- cells with high proliferative potential which sustain Ph-negative polyclonal hematopoiesis.
- Publication date
- Publisher
Abstract
Clinical observations on the ability of idarubicin-containing regimen and G-CSF to recruite CD34+/DR- cells that have high proliferative potential and can sustain Ph-negative polyclonal hematopoiesi
